Antiretroviral therapy coverage for PMTCT in Dominican Republic

Dominican Republic: Antiretroviral therapy coverage for PMTCT was 68.0% in 2024. ◆ Volatile

Latest (2024)
68.0%
Change on year
unchanged
World rank
54th
of 84 countries
All-time high
68.0%
in 2023
All-time low
0.0%
in 2000
Years of data
25
2000–2024

Antiretroviral therapy coverage for PMTCT in Dominican Republic, 2000–2024

02040602000201220242000: 0 % of pregnant women living with HIV2001: 0 % of pregnant women living with HIV2002: 2 % of pregnant women living with HIV2003: 3 % of pregnant women living with HIV2004: 13 % of pregnant women living with HIV2005: 22 % of pregnant women living with HIV2006: 24 % of pregnant women living with HIV2007: 31 % of pregnant women living with HIV2008: 38 % of pregnant women living with HIV2009: 35 % of pregnant women living with HIV2010: 29 % of pregnant women living with HIV2011: 41 % of pregnant women living with HIV2012: 51 % of pregnant women living with HIV2013: 39 % of pregnant women living with HIV2014: 44 % of pregnant women living with HIV2015: 37 % of pregnant women living with HIV2016: 39 % of pregnant women living with HIV2017: 35 % of pregnant women living with HIV2018: 33 % of pregnant women living with HIV2019: 29 % of pregnant women living with HIV2020: 23 % of pregnant women living with HIV2021: 39 % of pregnant women living with HIV2022: 51 % of pregnant women living with HIV2023: 68 % of pregnant women living with HIV2024: 68 % of pregnant women living with HIV

Source: UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS). Measured in % of pregnant women living with HIV.

Analysis

Dominican Republic recorded 68.0% for antiretroviral therapy coverage for pmtct in 2024. That is the highest value across all 25 years on record.

Compared with earlier readings it is up 54.5% over ten years.

Over the whole period, antiretroviral therapy coverage for pmtct in Dominican Republic peaked at 68.0% in 2023 and was at its lowest, 0.0%, in 2000.

That places Dominican Republic 54th out of 84 countries with data for 2024, putting it in the middle of the range.

The series is highly variable year to year, so single readings are best treated with caution.

Antiretroviral therapy coverage for PMTCT in Dominican Republic, year by year

Annual values for Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV) in Dominican Republic, 2000 to 2024.
Year % of pregnant women living with HIV Change
2000 0.0%
2001 0.0%
2002 2.0%
2003 3.0% +50.0%
2004 13.0% +333.3%
2005 22.0% +69.2%
2006 24.0% +9.1%
2007 31.0% +29.2%
2008 38.0% +22.6%
2009 35.0% -7.9%
2010 29.0% -17.1%
2011 41.0% +41.4%
2012 51.0% +24.4%
2013 39.0% -23.5%
2014 44.0% +12.8%
2015 37.0% -15.9%
2016 39.0% +5.4%
2017 35.0% -10.3%
2018 33.0% -5.7%
2019 29.0% -12.1%
2020 23.0% -20.7%
2021 39.0% +69.6%
2022 51.0% +30.8%
2023 68.0% +33.3%
2024 68.0% +0.0%

Dominican Republic compared with similar countries

  • Dominican Republic's 68.0% is below the median for upper middle income countries, which is 79.5%, 86% of the median. (22 countries reporting)
  • Dominican Republic's 68.0% is above the median for Latin America & Caribbean, which is 68.0%, 1.0× the median. (15 countries reporting)

Biggest year-on-year movements

Years where Antiretroviral therapy coverage for PMTCT in Dominican Republic changed far more than this series normally does. A large move can be a real event or a change in how the figure was measured — the source note below says who published it.

YearChange FromTo
2004 +333.3% 3.0% 13.0%

Averages by decade

DecadeAverage LowestHighest Years
2000s 16.8% 0.0% 38.0% 10
2010s 37.7% 29.0% 51.0% 10
2020s 49.8% 23.0% 68.0% 5

Countries ranked near Dominican Republic

  1. 51 Libya 70.0% compare
  2. 52 Burkina Faso 69.0% compare
  3. 52 Central African Republic 69.0% compare
  4. 54 Laos 68.0% compare
  5. 56 El Salvador 66.0% compare
  6. 56 Suriname 66.0% compare

See the full ranking of 99 places →

More health data for Dominican Republic

All data for Dominican Republic →

Frequently asked questions

What is antiretroviral therapy coverage for pmtct in Dominican Republic?
Antiretroviral therapy coverage for pmtct in Dominican Republic was 68.0% in 2024, according to UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS).
What is the highest antiretroviral therapy coverage for pmtct recorded in Dominican Republic?
The highest recorded value was 68.0% in 2023.
What is the lowest antiretroviral therapy coverage for pmtct recorded in Dominican Republic?
The lowest recorded value was 0.0% in 2000.
How does Dominican Republic rank for antiretroviral therapy coverage for pmtct?
Dominican Republic ranks 54th out of 84 countries with data for 2024.
Is antiretroviral therapy coverage for pmtct rising or falling in Dominican Republic?
Over the last ten years it is up 54.5%. The long-run trend across the full record is volatile.
Where does this Dominican Republic data come from?
The figures come from UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as part of Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV). Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).

Share, cite or embed this page

Cite this page

Antiretroviral therapy coverage for PMTCT in Dominican Republic. Statizoid, drawing on UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS). Retrieved 18 September 2026, from https://health.statizoid.com/stat/antiretroviral-therapy-coverage-for-pmtct-percent-of-pregnant-women-living-with-hiv/dominican-republic/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (World Bank Open Data); please keep the attribution.

<a href="https://health.statizoid.com/stat/antiretroviral-therapy-coverage-for-pmtct-percent-of-pregnant-women-living-with-hiv/dominican-republic/">Antiretroviral therapy coverage for PMTCT in Dominican Republic</a> — Statizoid

About this data

Indicator
Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)
Unit
% of pregnant women living with HIV
Source
UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS)
Licence
CC BY 4.0 (World Bank Open Data)
Coverage
99 places, 2,393 data points, 2000–2024
Last refreshed

Percentage of pregnant women with HIV who receive antiretroviral medicine for prevention of mother-to-child transmission (PMTCT).